Regulation of cytokine release and anti-tumor effect of anti-CD20 CAR modified expanded natural killer cells by ALT-803, an Il-15 superagonist

被引：0
|
作者：
Chu, Yaya [1 ]
Su, Nang Kham [1 ]
Hamby, Carl [2 ]
Jeng, Emily K. [3 ]
Alter, Sarah [4 ]
Barth, Mathew [5 ]
Wong, Hing C. [3 ]
Lee, Dean A. [6 ]
Cairo, Mitchell S. [1 ,7 ,8 ,9 ,10 ]
机构：
[1] New York Med Coll, Pediat, Valhalla, NY 10595 USA
[2] New York Med Coll, Microbiol & Immunol, Valhalla, NY 10595 USA
[3] HCW Biol, Miramar, FL USA
[4] Altor BioSci, Miramar, FL USA
[5] SUNY Buffalo, Dept Pediat, Buffalo, NY USA
[6] Nationwide Childrens Hosp, Hem Onc BMT, Columbus, OH USA
[7] New York Med Coll, Maria Fareri Childrens Hosp, Med, Valhalla, NY 10595 USA
[8] New York Med Coll, Maria Fareri Childrens Hosp, Pathol, Valhalla, NY 10595 USA
[9] New York Med Coll, Maria Fareri Childrens Hosp, Microbiol & Immunol, Valhalla, NY 10595 USA
[10] New York Med Coll, Maria Fareri Childrens Hosp, Cell Biol & Anat, Valhalla, NY 10595 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
89
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [21] Efficiently Targeting Metastatic Osteosarcoma, Neuroblastoma and Glioblastoma with Ex-Vivo Expanded Natural Killer Cells Combined with N-803 (ALT-803, IL-15 Superagonist) and TIM-3 Blockage
    Chu, Yaya
    Rosenblum, Jeremy
    Jeng, Emily K.
    Alter, Sarah
    Rhode, Peter R.
    Lee, John H.
    Lee, Dean
    Wong, Hing C.
    Cairo, Mitchell S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [22] Regulation of the Functions of Expanded Natural Killer (NK) Cells by N-820, an IL-15 Superagonist with 4 Single-Chain Anti-CD20 Antibody Domains Against Burkitt Lymphoma (BL)
    Chu, Y.
    Nayyar, G.
    Rosenblum, J.
    Jeng, E.
    Rhode, P.
    Lee, D.
    Wong, H.
    Lee, J.
    Cairo, M.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S426 - S426
  • [23] Combining Dinutuximab with ALT-803 (IL-15 Superagonist) Significantly Improves the Activity of Ex Vivo Expanded Natural Killer Cells Against GD2+ Pediatric Solid Tumors (ST)
    Nayyar, Gaurav
    Chu, Yaya
    Nang Kham Su
    Rosenblum, Jeremy
    Wong, Hing C.
    Lee, Dean
    Cairo, Mitchell S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S420 - S421
  • [24] REGULATION OF CYTOKINES/CHEMOKINES RELEASE AND ANTI-TUMOR EFFECT OF EXPANDED NATURAL KILLER (NK) CELLS BY A NOVEL FUSION OF N-820 (2B8T2M), AN IL-15 SUPERAGONIST WITH 4 SINGLE-CHAIN ANTI-CD20 ANTIBODY DOMAINS, AGAINST RITUXIMAB RESISTANT BURKITT LYMPHOMA (BL)
    Chu, Yaya
    Negron, Olivia
    Nayyar, Gaurav
    Rosenblum, Jeremy
    Jeng, Emily
    Alter, Sarah
    Rhode, Peter R.
    Lee, Dean A.
    Wong, Hing C.
    Lee, John H.
    Cairo, Mitchell S.
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [25] Cooperative therapeutic anti-tumor effect of IL-15 agonist ALT-803 and co-targeting soluble NKG2D ligand sMIC
    Basher, Fahmin
    Jeng, Emily K.
    Wong, Hing
    Wu, Jennifer
    ONCOTARGET, 2016, 7 (01) : 814 - 830
  • [26] Enhancing the Functional Activity of Natural Killer Cells Against Myeloid Leukemia with the IL-15 Super-Agonist, ALT-803
    Otegbeye, Folashade
    Mackowski, Nathan
    Ojo, Evelyn
    Moreton, Stephen
    de Lima, Marcos
    Wald, David
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S144 - S144
  • [27] Regulation of Cytokines/Chemokines Release and Anti-Tumor Effect of Expanded Natural Killer (NK) Cells By a Novel Fusion of N-820 (2B8T2M), an IL-15 Superagonist with 4 Single-Chain Anti-CD20 Antibody Domains, Against Rituximab Resistant Burkitt Lymphoma (BL)
    Chu, Yaya
    Su, Nang Kham
    Jeng, Emily K.
    Alter, Sarah
    Rhode, Peter R.
    Lee, John H.
    Nayyar, Gaurav
    Barth, Matthew J.
    Lee, Dean Anthony
    Wong, Hing C.
    Cairo, Mitchell
    BLOOD, 2018, 132
  • [28] The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles
    Webb, Gabriela M.
    Li, Shengbin
    Mwakalundwa, Gwantwa
    Folkvord, Joy M.
    Greene, Justin M.
    Reed, Jason S.
    Stanton, Jeffery J.
    Legasse, Alfred W.
    Hobbs, Theodore
    Martin, Lauren D.
    Park, Byung S.
    Whitney, James B.
    Jeng, Emily K.
    Wong, Hing C.
    Nixon, Douglas F.
    Jones, R. Brad
    Connick, Elizabeth
    Skinner, Pamela J.
    Sacha, Jonah B.
    BLOOD ADVANCES, 2018, 2 (02) : 76 - 84
  • [29] Combining ROR1-Specific Chimeric Antigen Receptor (CAR) NK Cells with IL-15 Superagonist (N-803/ALT-803) to Target Chemotherapy Resistant Neuroblastoma
    Nayyar, Gaurav
    Chu, Yaya
    Negron, Olivia
    Lyngdoh, Jeremy
    Jeng, Emily K.
    Alter, Sarah
    Rhode, Peter R.
    Lee, John H.
    Ayello, Janet
    Lee, Dean
    Wong, Hing C.
    Cairo, Mitchell S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [30] IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+T cells, and mediates potent anti-tumor activity of murine breast and colon carcinomas
    Kim, Peter S.
    Kwilas, Anna R.
    Xu, Wenxin
    Alter, Sarah
    Jeng, Emily K.
    Wong, Hing C.
    Schlom, Jeffrey
    Hodge, James W.
    CANCER RESEARCH, 2016, 76
12345